• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
  • View Item
  •   LillOA Home
  • Liste des unités
  • Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

The evolving landscape of brain metastasis
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique: Article de synthèse/Review paper
DOI :
10.1016/j.trecan.2018.01.003
PMID :
29506669
Permalink :
http://hdl.handle.net/20.500.12210/74963
Title :
The evolving landscape of brain metastasis
Author(s) :
Valiente, Manuel [Auteur]
Ahluwalia, Manmeet S. [Auteur]
Boire, Adrienne [Auteur]
Brastianos, Priscilla K. [Auteur]
Goldberg, Sarah B. [Auteur]
Lee, Eudocia Q. [Auteur]
Le Rhun, Emilie [Auteur]
Preusser, Matthias [Auteur]
Winkler, Frank [Auteur]
Soffietti, Riccardo [Auteur]
Journal title :
Trends in cancer
Abbreviated title :
Trends Cancer
Volume number :
4
Pages :
176-196
Publication date :
2018-03-01
ISSN :
2405-8025
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical ...
Show more >
Metastasis, involving the spread of systemic cancer to the brain, results in neurologic disability and death. Current treatments are largely palliative in nature; improved therapeutic approaches represent an unmet clinical need. However, recent experimental and clinical advances challenge the bleak long-term outcome of this disease. Encompassing key recent findings in epidemiology, genetics, microenvironment, leptomeningeal disease, neurocognition, targeted therapy, immunotherapy, and prophylaxis, we review preclinical and clinical studies to provide a comprehensive picture of contemporary research and the management of secondary brain tumors.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
INSERM
Université de Lille
Collections :
  • Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Submission date :
2022-06-15T13:57:34Z
Université de Lille

Mentions légales
Université de Lille © 2017